Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Personalized Medicine Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Early Detection/Screening, Indication, Treatment Selection, Monitoring), By Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By Region and Competition, 2019-2029F
... 2019-2029F Global Personalized Medicine Biomarkers Market was valued at USD 14.11 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In recent years, ... Read More
-
Pemphigus Vulgaris Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... to reach US$ 519.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.3% during 2024-2034. The pemphigus vulgaris market has been comprehensively analyzed in IMARC's new report titled "Pemphigus Vulgaris Market: Epidemiology, Industry Trends, ... Read More
-
Global Immunomodulators Databank Market Report
... segment is expected to be the highest contributor to this market, with $78,020.3 Million in 2020, and is anticipated to reach $151,171.1 Million by 2029, registering a CAGR of 7.67%. Oncology and Respiratory segments collectively ... Read More
-
Middle East and Africa Stem Cell Therapy Market, By Type (Allogenic Stem Cell Therapy, Autologous Stem Cell Therapy); By Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-derived MSCs, Placental/Umbilical Cord-derive MSCs); By Therapeutic Application (Musculoskeletal Disorders, Wounds & Surgeries, Cardiovascular Diseases, Inflammatory & Autoimmune, Neurological Disorders); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Middle East and Africa (MEA)), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Wounds & Surgeries, Cardiovascular Diseases, Inflammatory & Autoimmune, Neurological Disorders); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Middle East and Africa (MEA)), Trend Analysis, Competitive Landscape & Forecast, ... Read More
-
Blood Testing Market by Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application (Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders), End-User - Global Forecast 2024-2030
... USD 94.49 billion in 2023 and expected to reach USD 100.02 billion in 2024, at a CAGR 6.34% to reach USD 145.37 billion by 2030. Blood testing is a clinical procedure that involves analyzing a ... Read More
-
Specialty Injectable Generics Market Size, Trends, Analysis, and Outlook By Type (Drugs, Biologics), By Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... Generics market size is poised to register 8.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Specialty Injectable Generics market across By ... Read More
-
miRNA Sequencing and Assay Market Size, Trends, Analysis, and Outlook By Products and Services (Products, Services), By Technology (Sequencing By Synthesis, Sequencing By Oligonucleotide Ligation and Detection (SOLiD), Nanopore Sequencing, Sanger Sequencing, Single Molecule Real-time (SMRT) Sequencing), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-User (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), by Country, Segment, and Companies, 2024-2032
... (SMRT) Sequencing), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-User (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), by Country, Segment, and ... Read More
-
Hematology Market Size, Trends, Analysis, and Outlook By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, Others), By Reagent (Coagulation Reagents, Flow Cytometry Reagents, Immun-hematology Reagents, Others), By Application (Drug Testing, Auto-immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032
... Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032 The global Hematology market size is poised to register 5.8% growth from 2024 ... Read More
-
Biomarker Technologies Market Size, Trends, Analysis, and Outlook By Product (Instruments, Assay and Reagents, Consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, Others), By Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032
... Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032 The global Biomarker Technologies market size is poised to register 14.1% growth from 2024 to 2032, presenting significant growth prospects ... Read More
-
Biotechnology Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Others), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing), By Scale of Operation (Commercial Operations, Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Others), by Country, Segment, and Companies, 2024-2032
... Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, ... Read More
-
Plantibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Transgenic Crop (Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables, Others), By Technique (Conventional Method, Tissue Culture, Breeding & Sexual Crossing, Transgenic Seeds, Others), By Application (Autoimmune Diseases, Cancer, Infectious Diseases, Immunization, Dentistry, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others), By Region and Competition, 2019-2029F
... Transgenic Seeds, Others), By Application (Autoimmune Diseases, Cancer, Infectious Diseases, Immunization, Dentistry, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others), By Region and Competition, 2019-2029F Global Plantibodies Market was valued ... Read More
-
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032
... market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 172.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9.4% during 2024-2032. The rising number of ... Read More
-
Global Autoimmune Uveitis Market - 2023-2030
... forecast period 2023-2030. A rare but potentially dangerous eye disorder known as autoimmune uveitis is characterized by inflammation of the uvea, the central layer of the eye. Autoimmune uveitis can develop in any area of ... Read More
-
Autoimmune Gastritis - Pipeline Insight, 2024
... picture of the Autoimmune Gastritis pipeline landscape is provided, which includes the disease overview and Autoimmune Gastritis treatment guidelines. The assessment part of the report embraces in-depth Autoimmune Gastritis commercial assessment and clinical assessment of ... Read More
-
Autoimmune Hepatitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024
... growth prospects across the Autoimmune pulmonary alveolar proteinosis (aPAP) market. A detailed picture of the Autoimmune pulmonary alveolar proteinosis (aPAP) pipeline landscape is provided, which includes the disease overview and Autoimmune pulmonary alveolar proteinosis (aPAP) ... Read More
-
Autoimmune Encephalitis (AE) - Pipeline Insight, 2024
... (AE) market. A detailed picture of the Autoimmune Encephalitis (AE) pipeline landscape is provided, which includes the disease overview and Autoimmune Encephalitis (AE) treatment guidelines. The assessment part of the report embraces in-depth Autoimmune Encephalitis ... Read More
-
Fc and Glycoengineered Antibodies Market
... Disorders), Route of Administration (Intravenous, Subcutaneous and Intramuscular) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts The Fc and glycoengineered antibodies market is valued at ... Read More
-
Immunoglobulins Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 2022, and the market is now projected to grow from USD 16.24 billion in 2023 to USD 29.57 billion by 2030, exhibiting a CAGR of 8.9% during the forecast period of 2023-2030. The COVID-19 Pandemic ... Read More
-
Cutaneous Lupus Erythematosus – Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Cutaneous Lupus Erythematosus- Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Pemphigus Vulgaris - Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Global Autoimmune Disease Diagnosis Market
... during the forecast period. Advancements in Diagnostic Technologies: There's a continuous evolution in diagnostic technologies, including next-generation sequencing (NGS), multiplex assays, and digital pathology, enabling more accurate, sensitive, and efficient detection of autoimmune diseases. Companies ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
Eosinophilic Esophagitis Market, by Drug Class (Corticosteroids: Budesonide {Jorveza and Off-label budesonide} and Fluticasone; Proton Pump Inhibitor (PPI): Omeprazole, Esomeprazole, and Others; and Late Stage Pipeline Drugs: Dupixent, APT-1011, Lirentelimab (AK002), Cendakimab, Etrasimod, TAK-721, and Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - ... Read More
Research Assistance
